Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

filgrastim

EU orphan designation number: EU/3/08/532   
Active ingredient: filgrastim
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: NeuroVision Pharma GmbH
Emil-Geis-Straße 4, 82031 Grünwald, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/04/2008 Orphan designation EMEA/OD/102/07 (2008)1303 of 01/04/2008
30/04/2014 Transfer of orphan designation EMEA/OD/102/07/T/01 (2014)2908 of 28/04/2014
05/02/2015 Transfer of orphan designation EMEA/OD/102/07/T/02 (2015)637 of 02/02/2015